Speakers will be announced Fall 2025

Michael T. Lawton MD is the chairman of the Department of Neurological Surgery at the Barrow Neurological Institute, as well as its President and Chief Executive Officer and the Robert F. Spetzler Endowed Chair in Neurosciences.

He is chief of vascular and skull base neurosurgery, specializing in the surgical treatment of aneurysms, arteriovenous malformations, arteriovenous fistulas, cavernous malformations, and cerebral revascularization, including carotid endarterectomy. As the leader of the largest cerebrovascular center in the country, he has experience in surgically treating over 4500 brain aneurysms and over 900 AVMs. He also practices skull base tumor surgery and the endovascular treatment of aneurysms.

Dr. Lawton co-directs and conducts his research at the Barrow Aneurysm and AVM Research Center (BAARC), a collaborative research group funded by grants from the National Institutes of Health that investigates the physiology of cerebral circulation and the pathophysiology of vascular malformations. His basic science investigations study the formation, underlying genetics, and rupture of brain AVMs, as well as the hemodynamics, rupture, and computational modeling of brain aneurysms. His clinical investigations study the anatomy of microsurgical approaches to vascular lesions and the outcomes of aneurysm, AVM, and bypass surgery. He is the principle investigator of a NIH U54 grant and program director of the Brain Vascular Malformation Consortium (BVMC), a multicenter group studying malformations associated with Hereditary Hemorrhagic Telangiectasia, cavernous malformations, and Sturge Weber Syndrome.

He has published over 500 peer-reviewed articles, over 70 book chapters, and 6 textbooks, including Seven AVMs: Tenets and Techniques for Resection, Seven Bypasses: Tenets and Techniques for Revascularization, and Seven Aneurysms: Tenets and Techniques for Clipping, which has won numerous awards and sold more copies than Yasargil’s Microneurosurgery. His awards include the Young Neurosurgeon Award from the World Federation of Neurological Societies, the Harold Rosegay Teaching Award, and the Diane Ralston Clinical and Basic Science Teaching Award. He has given over 800 invited lectures nationally and internationally, including visiting professorships at over 50 neurosurgical institutions. He has been active in resident teaching, directing the CNS Anatomy Course for Senior Residents, co-directing the AANS Vascular Skills Course, and directing industry-sponsored anatomy courses. He sponsors an observership in vascular neurosurgery that has hosted more the 100 neurosurgeons and residents nationally and internationally. He co-founded Mission:BRAIN, a teaching mission to raise the level of neurosurgery practiced in developing countries, and has conducted 7 missions in Mexico and the Philippines.

J Mocco, MD, MS has dedicated his career to improving treatment options for acute stroke patients and advancing stroke systems of care.

He serves on the Joint Commission Technical Advisory Panel for thrombectomy-capable stroke centers and sits on the American Heart Association/American Stroke Association Quality Accreditation Science Committee. Dr. Mocco also serves as an international primary investigator for THERAPY and COMPASS, two landmark trials evaluating aspiration thrombectomy for emergent large vessel occlusion. He has published over 500 peer-reviewed papers on stroke care, is the past chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Cerebrovascular Section and is immediate past President, the Society of NeuroInterventional Surgery. Dr. Mocco received his medical degree from the Columbia University College of Physicians and Surgeons. He earned his Master of Science in biostatistics at the Mailman School of Public Health at Columbia University; he completed a residency in neurological surgery at the Neurological Institute of New York and a fellowship in endovascular neurosurgery at the University of Buffalo. He currently serves as a professor and senior system vice chair in the Department of Neurosurgery at Mount Sinai.

Dr. Adnan H. Siddiqui, is Professor and Vice Chairman in the Department of Neurosurgery at the State University of New York at Buffalo’s Jacobs School of Medicine and Biomedical Sciences.

Dr. Mocco also serves as an international primary investigator for THERAPY and COMPASS, two landmark trials evaluating aspiration thrombectomy for emergent large vessel occlusion. He has published over 500 peer-reviewed papers on stroke care, is immediate past chair of the American Association of Neurological Surgeons/Congress of Neurological Surgeons Cerebrovascular Section and is a board member of the Society of NeuroInterventional Surgery. Dr. Mocco received his medical degree from the Columbia University College of Physicians and Surgeons. He earned his master of science in biostatistics at the Mailman School of Public Health at Columbia University; he completed a residency in neurological surgery at the Neurological Institute of New York and a fellowship in endovascular neurosurgery at the University of Buffalo. He currently serves as a professor and senior system vice chair in the Department of Neurosurgery at Mount Sinai.

Dr. Fifi is a Professor of Neurology, Neurosurgery, and Radiology at the Icahn School of Medicine at Mount Sinai. She is also Associate Director of the Cerebrovascular Center, Co-Director of the Pediatric Cerebrovascular Disorders Program, and Co-Director of the Neuroendovascular Surgery Fellowship Program.

She is President-Elect of the Society of Neurointerventional Surgery and past board member of the Society of Interventional Neurology. Dr. Fifi has authored over 100 publications and is associate editor of the Stroke: Vascular and Interventional Neurology Journal. She has been actively involved and led a number of clinical research trials into adult and pediatric endovascular disease and stroke systems of care. She is a member and past committee chair of the Neuro-Endovascular Surgery Advisory Committee, an oversight committee governing training programs across our country. Dr. Fifi specializes in the endovascular treatment of cerebrovascular disorders including vein of Galen malformation, brain aneurysms, arteriovenous malformations and fistulas of the brain and spine, stroke, intracranial and carotid stenosis, as well as craniofacial vascular lesions in adults and children.

 Dr. Steven Giannotta, Professor and Chairman of Neurological Surgery, joined the Department of Neurosurgery at USC in 1980 and became the Chairman in 2004. He is also the Program Director of the Neurosurgery Residency Training Program.

He earned his medical degree from the University of Michigan, where he also did his neurosurgical residency. He is involved in many local, national and international committees and organizations.  On a national level, from 1996 until 1998, Dr. Giannotta served as Chairman of the Joint Section of Cerebrovascular Surgery of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. He was a Director of the American Board of Neurological Surgery from 1995-2001. After completing a term as Secretary from 1999-2000, he served as Chairman of the American Board of Neurological Surgery from 2000-2001. He served a term on the Board of Directors of the American Association of Neurological Surgeons and in 2008 completed a six year term on the Residency Review Committee for Neurosurgery (ACGME), the last two as Chair of the Committee. He was President of the American Academy of Neurological Surgeons from 2009-2010 and was Vice President of the Society of Neurological Surgeons from 2010-11. From 2008-2018 he served as the Secretary of the Committee on Advanced Subspecialty Training for the Society of Neurological Surgeons accrediting Neurosurgery fellowship training programs. 

He has special interests and expertise in two broad areas of neurological surgery. Dr. Giannotta has gained recognition for his work in cerebrovascular disease of the brain and spinal cord. He has surgically treated over 3000 intracranial aneurysms. Dr. Giannotta also has an interest and special expertise in surgical approaches to the cranial base. He has surgically removed more than 10000 acoustic neuromas and along with several colleagues in otolaryngology has developed a team approach to complex cranial base lesions including acoustic neuromas, meningiomas of the cranial base, complex aneurysms that require cranial base approaches and other benign conditions affecting the base of the brain and skull. Since 1992 he has developed one of the largest practices for the surgical treatment of trigeminal neuralgia with over 500 cases. 

Alexander Khalessi, MD, MBA, is chair of the Department of Neurological Surgery; professor of neurological surgery, radiology and neuroscience; and the inaugural Don and Karen Cohn Chancellor’s Endowed Chair in Neurosurgery at UC San Diego.

He has special interest and expertise in the performance of complementary microsurgical, radiosurgical and endovascular techniques for the comprehensive management of cerebrovascular conditions. This spectrum of disease includes aneurysms and arteriovenous malformations, as well as dural, cavernous and spinal fistulae. He has special interests in endovascular management of acute ischemic stroke, as well as endovascular and microsurgical management of extracranial and intracranial vascular occlusive disease.

Dr. Siddiqui has over 500 peer reviewed publications, more than 50 chapters, almost 70,000 citations and an H index of 72. He is particularly proud of representing Buffalo and the US at most major cerebrovascular conferences around the world with over 400 international presentations to date. He has designed, conducted and lead multiple major national and international clinical trials and currently serves as National and International PI for multiple major funded multi-site trials.

He serves as the CEO and CMO of the Jacobs Institute which is focused on entrepreneurship, development and education opportunities with partners in the medical technology industry to advance the care of patients with vascular diseases. He also leads the Canon Stroke and Vascular Research Center at University at Buffalo and serves as the Director of the Neurosurgical Stroke Service at the Gates Vascular Institute in Buffalo, one of the busiest Comprehensive Stroke Services in New York State and the United States.

Edward Duckworth, MD, MS, is an intracranial-focused neurosurgeon specializing in the treatment of complex cranial disorders, including the surgical treatment of hemorrhagic and ischemic stroke.

He is system director of neurosurgery for St. Luke’s and a voluntary clinical professor at UC San Diego. Dr. Duckworth holds the distinction of being dual fellowship-trained: in open cerebrovascular and cranial base surgery at Northwestern University and in endovascular neurosurgery/interventional neuroradiology at Semmes Murphey Neurologic and Spine Institute/ University of Tennessee Health Science Center. He has particular expertise in the treatment of complex aneurysms, arteriovenous malformations, carotid disease and cerebral hypoperfusion.

Adam Arthur, MD, MPH, attended college and medical school at the University of Virginia. During that time he joined the University of Virginia’s Department of Neurosurgery and conducted research on aneurysms and cerebral vasospasm.

He completed his internship and residency at the University of Utah, where he also completed his master’s degree in public health with a focus on clinical trials methodology. After finishing his neurosurgery residency, he joined the Semmes Murphey Clinic and the University of Tennessee Department of Neurosurgery. During his first two years in Memphis, he completed a fellowship in endovascular and cerebrovascular neurosurgery. He is one of the first neurosurgeons in the country to develop a busy practice in both open cerebrovascular surgery and endovascular neurosurgery. Now in his twentieth year in Memphis he holds the James T. Robertson Endowed Professor and Chair of the Department of Neurosurgery at UTHSC and is also the Chair of the AANS/CNS Joint Cerebrovascular Section and the Chair of the Neurosurgery Research and Education Foundation. He is currently leading six different large scale multicenter clinicial trials and is actively engaged in developing and testing innovative strategies to improve patients’ lives across a number of disease states.

Professor Donnan is a clinical stroke neurologist with long-standing research interests in acute stroke therapy and clinical trials. He conducted early trials of thrombolysis and more recently extending the time limit for tPA using image guided selection.

He has also contributed to the introduction of thrombectomy in trials such as EXTEND-IA. He is a former Director of the Florey Institute of Neuroscience and Mental Health and past President of the World Stoke Organization. He is currently Professor of Neurology at the University of Melbourne and Co-Chair, with Stephen Davis, of the Australian Stroke Alliance. This is a collaborative group embracing many organisations and disciplines across Australia to advance prehospital stroke care, particularly using lightweight brain imaging devices on road and in air. This program encompasses all Australians who may develop stroke, but particularly benefits rural, remote and Indigenous communities.

Brian T. Jankowitz, M.D. is a board certified neurosurgeon with a special focus on cerebrovascular surgery. He is CAST (Committee on Advanced Subspeciality Training) accredited in neuroendovascular surgery.

Dr. Jankowitz specializes in innovative treatments for ischemic and hemorrhagic stroke including carotid disease, intracranial stenosis, brain aneurysms, arteriovenous malformations (AVMs), and vascular malformations of the spine. He has extensive training in open and endovascular surgical procedures including CEA, TCAR, carotid stenting, aneurysm clipping, aneurysm coiling, and acute stroke interventions.

Prior to joining the Hackensack Meridian Neuroscience Institute at JFK University Medical Center, Dr. Jankowitz was the Division Head of Cerebrovascular Surgery at the Perelman School of Medicine at the University of Pennsylvania. He had previously served as the Director of the Cerebrovascular Program at Cooper Neurological Institute in Camden, New Jersey. He was also an associate professor of neurological surgery at the University of Pittsburgh School of Medicine and served as faculty of the UPMC Neurosurgery Department and UPMC Stroke Institute where he specialized in both open and endovascular neurosurgery.

Earning his bachelor of science degree from the University of Notre Dame, Dr. Jankowitz received his medical degree from Temple University School of Medicine. He then went on to complete his surgical internship, neurosurgical residency, and fellowship in Neuroendovascular surgery at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania.

Dr. Jankowitz is a member of the American Board of Neurological Surgeons, the Society of NeuroInterventional Surgery and the American Heart Association. He is also a member of the Congress of the Neurological Surgeons and the Endovascular Neurosurgery Research Group, and holds editorial positions on several national medical publications including The Spine Journal, World Neurosurgery, Neurosurgical Review, Interventional Neurology and the Journal of NeuroInterventional Surgery. He is also a primary investigator for several national clinical trials.

John Perl II, MD, is the director of neurointervention at St. Luke’s and formerly served as its neuroscience medical director. He was instrumental in establishing the stroke program and the endovascular neurosurgical and interventional neuroradiology program for the health system.

He completed his diagnostic radiology residency at the University of Alabama and his neuroradiology fellowship at the Cleveland Clinic Foundation. His neurointerventional radiology training was at the University of Wisconsin under one of the founders of neurointerventional therapies, Dr. Charlie Strothers. Prior to coming to St. Luke’s in 2010, Dr. Perl worked at Abbott Northwestern Hospital in Minneapolis and at the Cleveland Clinic Foundation. In his previous roles, he was active in fellowship education and translational science as well as actively developed some of the neurointerventional tools that are still in use today.

Lucas Elijovich, MD, earned his bachelor’s degree in biology from Tufts University and his medical degree from the University of Texas at Galveston. He completed his neurology residency at New York University, where he served as chief resident.

He pursued advanced interests in cerebrovascular disease, neurocritical care and interventional neuroradiology, completing fellowship training in stroke and neurocritical care at the University of California, San Francisco. He then trained with Dr. Alejandro Berenstein, one of the pioneers of interventional neuroradiology, in New York. Dr. Elijovich joined Semmes Murphey Clinic in 2010 and is a professor in the Departments of Neurology and Neurosurgery at the University of Tennessee Health Sciences Center. He also serves as director of neurocritical for the University and director of neurointerventional surgery and the Vascular Anomalies Center for LeBonheur Children’s Hospital.

Dr Alexandrov received his MD degree in 1989 from the 1st Moscow Medical Institute (Sechenov) and specialized in clinical neurology at the Institute of Neurology, Russian Academy of Medical Sciences, Moscow, Russia.

He completed his fellowship training in stroke and cerebrovascular ultrasound at the University of Toronto with Dr John W. Norris and at the University of Texas with Dr James C. Grotta, and also received mentoring from Drs Dmitry K. Lunev, Patrick M. Pullicino and Sandra E. Black.

Dr Alexandrov is listed among Banner Best Doctors by Phoennix Magazine 2024; by US News&World Report Best Doctors and America’s Top Doctors in Neurology, 2011-14 and 5/5 ranking in 2020-21; by Castle Connoly as top 1% of specialists in Neurology in 2011-17, by Expertscape as World Expert (0.1% of scholars publishing in the past 10 years) in Stroke, 2019 and Expert, Ultrasonic Therapy, 2021.

Dr Alexandrov published 323 original papers, 3 textbooks, 16 case reports, 164 review articles, editorials, invited publications, and book chapters & over 350 abstracts presented at major scientific meetings and published in refereed journals. Current h-index 79.

Dr Alexandrov has trained 61 fellows in stroke and cerebrovascular ultrasound. He served as Director of the Neurosonology Examination (1998-2018) and President of the American Society of Neuroimaging (2019-2021), Board member of the Intersocietal Accreditation Commission (IAC-Vascular, 2006-20, IAC-CT 2023-26), founding Editor-in-Chief, Brain and Behavior (2011-2015), past and present Editorial Board member of Stroke, Cerebrovascular Diseases, International Journal of Stroke, Journal of Neuroimaging, S:VIN (Senior Guest Editor), Annaly Klinicheskoi I Experimentalnoi Nevrologii and Nevrologia and past member of the Society of Vascular and Internional Neurology (SVIN) Board of Directors, and Program Committee, International Stroke Conference, American Heart Association. He is an active elected member of the American Neurological Association.

Dr Alexandrov specializes in development of novel reperfusion therapies for stroke. As Semmes Murphey Professor and Chair of the University of Tennessee Health Science Center Neurology Department (2013-2023), he directed Mobile Stroke Unit, the first in the world equipped with state-of-the-art CT scanner performing head and neck CTA and accredited by IAC as CT laboratory, and created Memphis city-wide Neuro-critical Care, Epilepsy and Stroke Programs that achieved and sustained the highest per capita treatment rates with tPA and mechanical thrombectomy in the world in 2015-2022. In 2023, he became the inaugural Chair of the Department of Neurology, University of Arizona College of Medicine – Phoenix.

Anne Alexandrov, PhD, AGACNP-BC, ANVP-BC, FAAN, is a professor of both nursing and neurology as well as the mobile stroke unit chief nurse practitioner at the University of Tennessee Health Science Center in Memphis.

She is also the professor and program director for Neurovascular Education and Training in Acute Stroke Management and Reperfusion Therapies (NET SMART) at the Health Outcomes Institute in Fountain Hills, Arizona. Developed in 2007, NET SMART is the world’s first and only post-graduate fellowship training program for advanced practice nurses in acute stroke. Through this program, she has mentored more than 150 APNs from across the U.S. and internationally.

Dawn Meyer is a Professor in the UC San Diego School of Medicine, Neurosciences Department and a member if the UC San Diego Stroke Center. She is a trained Vascular Neurology Nurse Practitioner and has been in practice for 21 years as a Stroke Hospitalist.

She trained in Vascular Neurology at the University of Texas Health Science Center at Houston, completed her PhD at UCLA focusing on antiplatelets and sex differences in a preclinical model of stroke, and has been a faculty member of UCSD School of Medicine for 13 years. The overarching focus of her research is the interaction of platelet aggregation, sex differences, and depression in acute stroke. Her daily clinical practice focuses on the acute diagnosis, treatment, and risk factor modification in ischemic stroke, transient ischemic attack, and intracerebral hemorrhage patients.  She was the first to show that antiplatelet loading improved stroke behavioral outcome in a preclinical model of ischemic stroke. In 2013, she was elected as a Fellow to the American Heart Association. She has published in top-tier stroke journals and has been a co-investigator in over 50 clinical stroke studies, site PI in 4 NIH studies, and PI of two NIH grants. Her current work focuses on the entire spectrum of stroke from translational to outcome studies with emphasis on antiplatelets.

Dr. Starke is a member of the departments of Neurological Surgery, Neuroradiology, Pharmacology, and Neurosciences. He has a busy clinical practice performing more than 700 operations each year.

He specializes in the treatment of cerebral vascular disease.

Dr. Starke is currently a tenured Professor of Neurological Surgery and Radiology at the University Of Miami MILLER School Of Medicine. Previously, he graduated magna cum laude with a B.A. from Princeton University and distinction in neuroscience. He obtained his medical doctorate from Albert Einstein graduating with distinction in clinical and translational research. He also obtained a Masters of Medical Science with distinction in neuroscience research as part of the National Institute of Health Clinical Research Training Program. He also completed a cerebral vascular research fellowship at Columbia University, which provided him with a wide background in epidemiology and statistics. Dr. Starke attended neurosurgery residency at the University of Virginia. He also completed endovascular neuroradiology fellowships at Thomas Jefferson University and University of Virginia and a cerebral vascular and skull base fellowship at Auckland University Hospital, New Zealand. He is board certified in Neurosurgery ABNS and certified by the Committee on Advance Subspecialty Training in Endovascular Therapies (CAST).

His laboratory is supported by multiple grants including more than 3 million dollars from the National Institute of Health to study aneurysms. His research focuses on cerebral vascular pathophysiology. These avenues allow for the development of novel cellular, medical, radiographic, surgical, and endovascular techniques. He has co-authored over 700 academic publications. As the Director of Neurovascular Research, he helps run numerous clinical trials for minimally invasive treatment of cerebral vascular disease and brain tumors.

Dr. Smith is a fellowship-trained neurointerventional radiologist with expertise in minimally invasive procedures of the brain, head, neck and spine. He specializes in both arterial and venous approaches for the treatment of many cerebrovascular disorders

including pulsatile tinnitus, idiopathic intracranial hypertension, spontaneous intracranial hypotension, cerebrospinal fluid venous fistulas, dural arteriovenous fistulas, arteriovenous malformations, stroke, brain aneurysms and other vascular disorders. Dr. Smith’s other interests include neurointerventional robotics, treatment of congenital vascular anomalies, and MRI-guided, focused ultrasound for the treatment of movement disorders such as essential tremor and Parkinson’s disease. After finishing his diagnostic radiology residency at the Medical College of Wisconsin, Dr. Smith completed diagnostic and interventional neuroradiology fellowships at the University of California, San Francisco.

J. Scott Pannell, MD is a board-certified endovascular surgeon and interventional neuro-radiologist. He is the director of neurointerventional surgery in the Department of Neurological Surgery at UC San Diego Health.

Dr. Pannell earned his bachelor’s degree in chemistry from the University of Georgia, along with an additional American Chemical Society certification, and his medical degree from the Medical College of Georgia. He completed his fellowships in endovascular neurosurgery and neuroradiology at University of California San Diego School of Medicine; his radiology residency at the University of Alabama at Birmingham; and his internship at Emory University. As an associate professor in the Departments of Neurological Surgery and Radiology, Dr. Pannell instructs medical students, residents and fellows in both departments. He specializes in the minimally invasive catheter-based treatment of blood vessel disorders that can lead to hemorrhagic or ischemic strokes. He is currently involved in multiple National Institutes of Health and industry-funded research projects investigating cerebrovascular diseases and spinal pain disorders. Dr. Pannell has co-authored more than 50 peer-reviewed journal articles and more than 30 book chapters; he is also a reviewer for multiple journals, including World Neurosurgery and the Journal of Neurointerventional Surgery. He has given over 40 lectures and presentations at national meetings.

Brett C. Meyer, MD, is a Stroke Neurologist and Co-Director of the Stroke Center at UCSD Medical Center, and is a Professor of Clinical Neurosciences in the Department of Neurosciences at the University of California, San Diego.

He is the Clinical Director of Telehealth Operations for the UCSD Telehealth Program. He is Board certified in Neurology, and subspecialty Board certified in Cerebrovascular diseases, by the American Board of Psychiatry and Neurology. He specializes in acute cerebrovascular disease therapies and technological evaluation and treatment techniques as the Director of UCSD Stroke Telehealth network and initiatives.
Dr. Meyer’s clinical research is varied, encompassing clinical stroke scale evaluations, acute and hyper- acute therapies for stroke, and Internet applications of telemedicine for the evaluation and treatment of stroke. Dr. Meyer was the Principal Investigator for an NIH-SPOTRIAS clinical trial assessing the use of telemedicine in acute stroke management. He is currently the PI of a Regional Coordinating Center for NIH StrokeNet, which is developing late phase stroke therapies for acute, prevention, and rehabilitation.
In his role as Clinical Director of Telehealth Operations, he is responsible for the clinical development, implementation, and medical oversight of numerous telehealth initiatives for primary care and all specialties throughout the entire health system and its external partners. Dr. Meyer has presented at major academic meetings, and has been published in numerous journals including Lancet Neurology, Annals of Neurology, Stroke, Neurology, The International Journal of Stroke, The Journal of Stroke and Cerebrovascular Diseases, Academic Medicine, and Quality Management in Healthcare.

Scott McNally, MD, PhD, is currently an associate professor in neuroradiology at the University of Utah Department of Radiology and Imaging Sciences.

His clinical and research interests are in using vessel wall imaging to better diagnose and treat atherosclerotic plaque and vascular pathology. His neurovascular research group is actively investigating imaging markers of vascular pathology and  downstream consequences in multicenter trials funded by the NIH and VA.

Dr. Martinez specializes in the treatment of a wide array of complex brain, spine and peripheral nerve conditions. He has expertise in surgery for brain and spine tumors, complex spine care, radiosurgery, cerebral hemorrhages, normal-pressure hydrocephalus (NPH) and general neurosurgery.

He also performs surgery for neuromodulation and the treatment of movement disorders and epilepsy. He is fellowship-trained in stereotactic and functional neurosurgery and experienced in deep brain stimulation (DBS) surgery.  Dr. Martinez earned his medical degree from Wayne State University School of Medicine. He completed his residency at University of Illinois and his fellowship at Stanford University. Prior to his medical education, Dr. Martinez earned his bachelor’s degree from Brigham Young University-Idaho and master’s degree in neuroscience from Brigham Young University. He is a member of the Congress of Neurological Surgeons, and the American Society for Stereotactic and Functional Neurosurgery.

Dr. Grandhi is an ABNS certified, dual-trained cerebrovascular neurosurgeon who treats vascular pathologies through both endovascular techniques and traditional, open microsurgical approaches.

He has extensive experience with patients with cerebrovascular conditions such as arteriovenous malformations, brain aneurysms, and intracranial hemorrhages. In addition, he has a significant interest in treating patients with stroke and uses minimally-invasive approaches ranging from carotid and intracranial stenting to mechanical thrombectomy for large vessel occlusions. He received his undergraduate degree from Duke University and a master’s degree in physiology at Georgetown University. Dr. Grandhi attended medical school at Virginia Commonwealth University and did his residency at the University of Pittsburgh Medical Center, where he completed an enfolded fellowship in Interventional Neuroradiology. He then completed a fellowship in Cerebrovascular Neurosurgery at the Baptist Neurological Institute in Jacksonville, Florida.

Raymond Grams, DO, specializes in the treatment of ischemic and hemorrhagic strokes, transient ischemic attack, cerebral venous thrombosis, and intra- and extra-cranial atherosclerotic disease.

His clinical interests include cardioembolic sources of stroke, arterial dissection and other causes of stroke in young people; evaluation for carotid stenting or endarterectomy; and neurosonology. Dr. Grams has been a co-investigator of nine stroke trials and has published and presented original research on the use of perfusion MRI in acute stroke imaging. He was a clinical instructor at the University of Utah prior to joining St. Luke’s, where he now serves as director of the neurohospitalist program.

Daniel Abenroth, MD, is the clinical system director for the St. Luke’s Stroke Program, the largest medical system and stroke program in Idaho.

As system clinical director, he broadly oversees the system medical management of ischemic stroke, hemorrhagic stroke and associated cerebrovascular care spanning nine Emergency Departments, three Joint Commission Stroke Centers and outpatient care. He also works as a neurohospitalist for St. Luke’s. He attended Brigham Young University for undergraduate studies, Michigan State University for medical school, University of Utah for his neurology residency and the Medical University of South Carolina for his vascular neurology fellowship. Dr. Abenroth’s clinical interests include intracranial atherosclerosis, critical care management of cerebrovascular disease and stroke systems of care

Professor Stephen Davis is the Professor of Translational Neuroscience at the University of Melbourne, Director of the Melbourne Brain Centre at the Royal Melbourne Hospital.

He is a Past-President of the World Stroke Organization, and co-chairs the Melbourne Mobile Stroke Unit Program (with Geoffrey Donnan).

Awards include the 2011 William Feinberg Award from the American Stroke Association, 2012 Karolinska Award, 2014 JJ Wepfer Award, 2017 C Miller Fisher Visiting Professor at the Massachusetts General Hospital/Harvard, 2018 Stroke Leadership Award (WSO), 2019 Chinese Stroke Association International Cooperation Award, 2021 Officer of the Order of Australia, 2022 Australian Cardiovascular Alliance Award.

His research has focussed on acute therapy for both ischemic stroke and intracerebral haemorrhage, particularly the use of advanced imaging in selection of therapy. He Co-Chairs (with Geoffrey Donnan) the Australian Stroke Alliance, aiming to deliver pre-hospital stroke care to rural and remote Australians using novel, lightweight brain scanners. He has an h-index of 106 and has published over 600 peer-reviewed research papers.

Jeffrey Steinberg, MD, is a neurosurgeon at UC San Diego Health who specializes in vascular diseases of the nervous system. Dr. Steinberg completed specialized training in both open and endovascular neurosurgery;

this includes traditional open neurosurgical procedures, such as aneurysm clipping, as well as minimally invasive endovascular procedures, such as aneurysm coiling. He also specializes in cerebral bypass procedures. Dr. Steinberg completed his neurosurgery training and a fellowship in neuroendovascular surgery at UC San Diego School of Medicine. He spent additional time at Stanford Medical Center with a focus on open cerebrovascular neurosurgery and moyamoya disease. During his residency, he received the Kaiser Excellence in Teaching Award. Currently, he is the director of the neurosurgical resident skull base lab, where he has contributed to the development of a novel surgical technique for the treatment of trigeminal neuralgia. Dr. Steinberg has published numerous manuscripts in peer-reviewed journals and regularly presents at national conferences. He is a member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons and the North American Skull Base Society.